📋 Tender Overview
Scope : To Set up Injectable Facility in Hyderabad, Telangana
One of the leading vaccine manufacturers in the country, Bharat Serums and Vaccines Limited (BSV) is planning to set up a state-of-the-art injectable facility in Hyderabad.
The company has acquired 10 acres of land in Genome Valley, the life sciences hub, which is India’s first organised cluster for life sciences R&D and clean manufacturing activities. It is estimated that BSV will need around Rs 200 crore for establishing the injectable facility. The facility will be ready in three years.
It will be one on the lines of Ambernath facility in Maharashtra which is involved in the manufacture of general categories of products, human biological and equine biological products, thrombolytic categories of products and urinary hormone products. Each has four dedicated injectable lines.
On September 2023, Biotech firm Bharat Serums and Vaccines (BSV) laid the ground-breaking ceremory for its new bio-pharmaceutical manufacturing plant in the presence of Industries and IT Minister KT Rama Rao on 21 September, 2023, at Genome Valley in Hyderabad, Telangana.
In Phase-I, BSV seeks to expand its capacity in manufacturing injectables with the commissioning of the fill-finish formulation line and plans to add multi-product lines in Phase-II of the project.
The company seeks to provide long-term employment opportunities and upskilling to the locals. BSV operates a manufacturing plant in Ambernath, Maharashtra, which caters to the domestic requirements and over 80 export markets.
